draft
 

List of Participating Companies

BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and mid-size pharmaceutical companies, investors and other industry experts.

Number of companies: 165
A Top of Page
AACC United States
Adherex Technologies Inc. United States
Adnexus Therapeutics United States
Agensys-Astellas Group United States
AIM Therapeutics Inc. Canada
Ajinomoto Co. Japan
ALGENEX Spain
AllerPharma Canada
AllTranz United States
Alpharma Pharmaceuticals United States
Alseres Pharmaceuticals Inc. United States
Altea Therapeutics United States
Alvine Pharmaceuticals United States
Amgen United States
AMRI United States
Apogenix GmbH Germany
Applied Pharma Research USA United States
Aquapharm Biodiscovery United Kingdom
AstraZeneca Canada Inc. Canada
Avecia Biologics ltd United Kingdom
Averion International United States
B Top of Page
Bach Pharma Inc United States
Bar-Ilan Research & Development Company Ltd. Israel
Bayer Schering Pharma AG Germany
BEIJING MINHAI BIOTECHNOLOGY CO. LTD China
BioBusiness Strategies United States
BIOCOM United States
BioCure Inc. United States
Biolex Therapeutics United States
BioMarck Pharmaceuticals United States
Bionor Immuno Norway
BioSante Pharmaceuticals Inc. United States
BIOTECanada Canada
BIOTECHNOLOGY CENTER OF GEORGIA Georgia
Biotechnology Investment Opportunity United States
BioUetikon Ltd. United States
BioWa Inc. United States
BioWorld Today United States
Britannia Pharmaceuticals Ltd United Kingdom
Brookwood Pharmaceuticals United States
C Top of Page
Campbell Alliance United States
Celladon Corporation United States
Cempra Pharmaceuticals Inc United States
Center for Disease Control and Prevention United States
CMIC Co. Ltd. Japan
CoMentis Inc. United States
Compendia Bioscience United States
CXR Biosciences Ltd. United Kingdom
D Top of Page
Dako Norden A/S Denmark
Debiopharm S.A. Switzerland
Demy-Colton Life Science Advisors United States
DiObex United States
DIREVO Biotech AG Germany
DNA Bridges United States
DOR BioPharma Inc. United States
E Top of Page
EBD Group Inc. United States
ECZACIBASI ILAC PAZARLAMA A.S. Turkey
Eli Lilly and Company United States
EMD Serono Canada Inc. Canada
Endacea Inc. United States
EnVivo Pharmaceuticals United States
ERA Consulting Group United Kingdom
Ergonex Pharma GmbH Switzerland
Eshelman School of Pharmacy University of North Carolina at Chapel Hill United States
Evotec (UK) Ltd United Kingdom
Expression Genetics (EGEN) United States
F Top of Page
FGK Clinical Research GmbH Germany
FHR Consult Germany
Fish & Richardson United States
Flamel Technologies Inc United States
Frost & Sullivan India
G Top of Page
Gai & Partner Switzerland
GC-University Pakistan
Genaera Corporation United States
GeneCure Biotechnologies United States
Georgia Venture Partners United States
GeriGene Medical United States
H Top of Page
H.I.G. Ventures United States
Hemispherx Biopharma Inc. United States
I Top of Page
ICAGEN, INC. United States
ImmunoVaccine Technologies Inc. Canada
Inhibitex, Inc. United States
Inspire Pharmaceuticals, Inc. United States
InterMed Discovery GmbH Germany
InTouch Life Sciences United States
ISU Abxis South Korea
Izun Pharma Ltd Israel
J Top of Page
Jurag Separation A/S Denmark
K Top of Page
KBI Biopharma Inc. United States
KemPharm Inc. United States
L Top of Page
Labopharm Inc. Canada
Laboratory for Personalized Molecular Medicine United States
Lentigen Corporation United States
LEO Pharma A/S Denmark
Life Science Analytics United States
LifeCycle Pharma United States
Luna Innovations Incorporated United States
Lux Biosciences Inc. United States
M Top of Page
McDonnell Boehnen Hulbert & Berghoff LLP United States
MDRNA Inc. United States
Medical College of Wisconsin United States
MedImmune United States
Merck Frosst Canada Ltd Canada
Merck Ltd. India
MorphoSys AG Germany
MP Healthcare Venture Management United States
Mutabilis France
N Top of Page
NanoDel Technologies GmbH Germany
NanoString United States
Neal, Gerber & Eisenberg LLP United States
Neurim Pharmaceuticals Ltd. Israel
Neurologix Inc. United States
NexGenix Pharmaceuticals United States
Norgenix Pharmaceutical LLC United States
Norgine Ltd United Kingdom
North Carolina Biotechnology Center United States
NovaBiotics United Kingdom
Novacta Biosystems Limited United Kingdom
Novartis Pharma AG Switzerland
Novo Nordisk Denmark
NuPathe Inc. United States
Nycomed Switzerland
O Top of Page
Oncolytics Biotech Inc. Canada
OncoMune United States
ONO PHARMA Japan
P Top of Page
PARI Pharma GmbH Germany
Pfizer Inc. United States
Phares Drug Delivery AG Switzerland
PharmaEssentia Corp. Taiwan
PharmaNav LLC United States
PharmaSurgics Sweden
PolyMedix Inc. United States
Prediction Sciences United States
Protherics PLC United Kingdom
R Top of Page
Recordati S.p.A. Italy
Rentschler Biotechnologie GmbH Germany
Reviva Pharmaceuticals Inc. United States
Revotar Biopharmaceuticals AG Germany
Roche United States
S Top of Page
S*BIO Pte Ltd Singapore
Samyang Corporation South Korea
Sanova Pharma GesmbH Austria
Semafore Pharmaceuticals Inc. United States
Senesco Technologies Inc. United States
Shire Pharmaceuticals United Kingdom
SP Pharmatech Pvt. Limited India
Supernus Pharmaceuticals Inc. United States
Symphogen Denmark
SynCo Bio Partners Netherlands
T Top of Page
Takeda Pharmaceutical North America United States
Targacept United States
TCG BioPharma United States
The Hamner Institutes for Health Sciences United States
TKR College of Engg.&Technology India
Transave Inc. United States
Transgeneron Therapeutics Inc. United States
TransPharma Medical Ltd. Israel
U Top of Page
UCB S.A. United States
UK Trade and Investment United States
University of Pittsburgh United States
V Top of Page
Van Andel Institute United States
Venture Valuation Switzerland
Victory Pharma Inc. United States
VM Discovery Inc. United States
Vogel Media Group China

 

 


 
 
Registration News
>> Delegates from 22 countries are already registered.

Registration Contact
Elaine Bundy
EBD Group
Phone +1 (760) 930 0500
Fax +1 (760) 930 0520
ebundy@ebdgroup.com
 
Companies located in Europe may also contact:
Philipp Dormeier
EBD Group
Phone +49 (89) 23 88 756 - 0
Fax +49 (89) 23 88 756 - 55
pdormeier@ebdgroup.com

 
       
© 2008 EBD Group, Inc.
EBD Group